Article

Association of IDH1 Mutation and MGMT Promotor Methylation with Clinicopathological Parameters in Adults with Gliomas in England

2024-10-15

Abstract excerpt

<h4>Background: </h4> - Molecular profiles can predict which patients will respond to current standard treatment and new targeted therapy regimens. Using data from a highly diverse population of approximately three million in Southeast London and Kent, this study aims to evaluate the prevalence of IDH1 mutation and MGMT promotor methylation in the gliomas diagnosed in adult patients and to explore correlations wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 09ba0b6f-cc2f-5203-a81c-364984c182b7
DOI: 10.20944/preprints202410.1135.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association of IDH1 Mutation and MGMT Promotor Methylation with Clinicopathological Parameters in Adults with Gliomas in EnglandDOI 10.20944/preprints202410.1135.v1Read

Association of IDH1 Mutation and MGMT Promoter Methylation with Clinicopathological Parameters in an Ethnically Diverse Population of Adults with Gliomas in EnglandSemantic proximity Read

Clinical Impact of <i>IDH1</i> Mutations and <i>MGMT</i> Methylation in Adult Glioblastoma MultiformeSemantic proximity Read

Clinical Impact of IDH1 Mutations and MGMT Methylation in Adult GlioblastomaSemantic proximity Read

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.Semantic proximity Read

Molecular landscape of IDH-wild-type, H3-wild-type glioblastomas of adolescents and young adults.Semantic proximity Read

Molecular neuro-oncology in clinical practice: a new horizon.Semantic proximity Read

DNA methylation and survival differences associated with the type of IDH mutation in 1p/19q non-codeleted astrocytomasSemantic proximity Read

Comparative Analysis of the Prognostic Significance of IDH,TERT, EGFR and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study.Semantic proximity Read

Impact of IDH mutation and MGMT methylation as Independent prognostic markers in uniformly treated high grade glioma Patients: A Real-World evidence in the Indian Population.Semantic proximity Read

The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimenSemantic proximity Read

The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations.Semantic proximity Read

Tumor Mutational Burden Predicts Survival In Patients With Low Grade Gliomas Expressing Mutated IDH1Semantic proximity Read